The National Human Genome Research Institute has funded a multi-institutional Center of Excellence in Genome Sciences (CEGS) , based at Weill Cornell Medicine, to develop new tools to study the major product of the human... Read more
Treatment with arginine, one of the amino-acid building blocks of proteins, enhanced the effectiveness of radiation therapy in cancer patients with brain metastases, in a proof-of-concept, randomized clinical trial from... Read more
Lymphomas can turbo-charge their ability to proliferate by crowding growth-supporting enzymes into highly concentrated compartments within tumor cells, according to a study led by researchers at Weill Cornell Medicine. The... Read more
A team led by researchers at Weill Cornell Medicine, the New York Genome Center , Harvard Medical School , Massachusetts General Hospital and the Broad Institute of MIT and Harvard has profiled in unprecedented detail... Read more
Illustration of B cells, antibodies and red blood cells. Credit: Shutterstock The master regulator behind the development of antibody-producing cells has been identified in a study by investigators at Weill Cornell Medicine... Read more
Multiplex immunofluorescence image of immune cell-infiltrated human colorectal cancer. Tumor cells are labeled with PKCi (magenta), immune cells are labeled with CD8 (red) and nuclei in white. Image courtesy of Dr. Jorge... Read more
Primary Image Description & Credit: Immunofluorescent images of lungs treated with radiation (left) or no radiation (right). Club cells secrete more anti-immunosuppressive factors when treated with radiation, as seen by... Read more
A team co-led by scientists at Weill Cornell Medicine has revealed in detail how the most common primary eye cancer in adults, uveal melanoma (UM), can progress from a slow-growing, “indolent” state to a lethal metastasizing... Read more
Cheryl Bonder had been living with a vaguely defined blood malignancy for years when her prognosis rapidly took a turn for the worse: her condition was progressing toward acute myelogenous leukemia (AML), an aggressive... Read more
Left: Low and high magnification images of small intestine from healthy mice treated with water or high-fructose corn syrup for 4 weeks. Right: Schematic illustrating how fructose promotes cell survival and increased villi... Read more
An immune cell subset called innate lymphoid cells (ILC3s) protects against colorectal cancer, in part by helping to maintain a healthy dialogue between the immune system and gut microbes, according to a new study led by... Read more
A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The... Read more
A powerful immune-suppressing molecule produced by the body may hold the key to better treatments for autoimmune and inflammatory diseases, as well as for some cancers, according to a study by researchers at Weill Cornell... Read more
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital. The preclinical results... Read more
Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment, according to a phase 2 clinical trial led by researchers... Read more
Single-cell RNA sequencing of prostate cells from mice with alterations in Pten, RB1 and MYCN identified 10 major cell subtypes and enabled researchers to study tumor heterogeneity with unprecedented resolution. Credit: Dr... Read more
Early cancer detection can make all the difference for a patient. Yet many cancers aren’t diagnosed until it’s too late. Drs. Dan Landau and Asaf Zviran are working to develop ultra-sensitive blood tests – called “liquid... Read more
A study from researchers at NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health, in... Read more
Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer led by Weill Cornell Medicine... Read more
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and... Read more
